Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Adagio Medical Holdings (ADGM) EBIAT (2023 - 2026)

Adagio Medical Holdings has reported EBIAT over the past 4 years, most recently at -$7.0 million for Q1 2026.

  • Quarterly EBIAT rose 9.16% to -$7.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$25.7 million through Mar 2026, down 44.17% year-over-year, with the annual reading at -$24.3 million for FY2025, 54.8% up from the prior year.
  • EBIAT was -$7.0 million for Q1 2026 at Adagio Medical Holdings, down from -$4.6 million in the prior quarter.
  • Over five years, EBIAT peaked at $3.6 million in Q3 2024 and troughed at -$10.8 million in Q3 2023.
  • The 4-year median for EBIAT is -$7.3 million (2025), against an average of -$6.3 million.
  • Year-over-year, EBIAT soared 133.51% in 2024 and then crashed 380.09% in 2025.
  • A 4-year view of EBIAT shows it stood at -$8.6 million in 2023, then soared by 141.83% to $3.6 million in 2024, then plummeted by 227.87% to -$4.6 million in 2025, then tumbled by 51.7% to -$7.0 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's EBIAT are -$7.0 million (Q1 2026), -$4.6 million (Q4 2025), and -$10.1 million (Q3 2025).